In 2017, the penny stock market experienced significant volatility and high-reward opportunities, with some stocks recording gains exceeding 600% year-to-date. Leading performers often emerged from the healthcare, biotechnology, and technology sectors due to clinical trial breakthroughs or strategic partnerships.
: A speculative restaurant play with a one-year price target significantly above its 2017 trading range.
: A standout performer in late 2017 with a 240.4% gain reported in October. cheap penny stocks to buy 2017
: Noted for a 113.8% gain in March.
: Identified as a strong tech opportunity due to its defense-related trainers and drone solutions. Healthcare & Biotech In 2017, the penny stock market experienced significant
: Despite solar market pressure, it gained 52.5% in early 2017 as a leader in microinverters. Speculative Gainers to Watch
Gained by October following successful epilepsy drug trials. MTBC Medical Transcription Billing : A standout performer in late 2017 with a 240
: Surged 60.1% in early January as it developed treatments for Alzheimer's and Parkinson's. Consumer & Industrial